Kathy L. McGraw
YOU?
Author Swipe
View article: Figure S5 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S5 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data showing Malat1 depletion has no effect on myelopoiesis or self-renewal
View article: Figure S7 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S7 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 6 but which were not included in the main figure
View article: Table S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Table S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Taqman assays for murine cytokine gene expression (related to Fig S6)
View article: Figure S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 5 but which were not included in the main figure
View article: Figure S1 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S1 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 1 but which were not included in the main figure
View article: Figure S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 3 but which were not included in the main figure
View article: Table S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Table S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
qRT-PCR primers for confirming MALAT1 knockout across transcript. (Related to Fig S7)
View article: Figure S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 4 but which was not included in the main figure
View article: Figure S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 2 but which were not included in the main figure
View article: Table S5 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Table S5 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
primer sequences for EGR1 Chromatin Immunoprecipitation (ChIP) (related to Fig S2)
View article: Data from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis
Data from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis Open
Even though the Ten-eleven translocation (TET) enzymes catalyze the generation of 5-hydroxymethylcytosines required for lineage commitment and subsequent differentiation of stem cells into erythroid cells, the mechanisms that link extracel…
View article: Supplementary Table 1 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis
Supplementary Table 1 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis Open
Supp Table 1: Transcripts associated with loss of cytosine methylation and increased gene expression in FDCP cells with JAK2V617F compared to FDCP with WT Jak2
View article: Supplementary Table 4 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis
Supplementary Table 4 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis Open
Supp Table 4: Loci that are differentially methylated in IMF with JAK2V617F mutations when compared to controls
View article: Supplementary Figures S1-S7 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis
Supplementary Figures S1-S7 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis Open
Supplementary Figures S1-S7
View article: Supplementary Table 6 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis
Supplementary Table 6 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis Open
Supp Table 6: Transcripts underexpressed in IMF samples with JAK2V617F mutation
View article: Supplementary Table 7 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis
Supplementary Table 7 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis Open
Supp Table S7 : Functional pathways differentially expressed and hydroxymethylated in Jak2V617F murine samples
View article: Supplementary Table 2 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis
Supplementary Table 2 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis Open
Supp Table 2: Patient Characteristics of IMF patients
View article: Supplementary Table 5 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis
Supplementary Table 5 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis Open
Supp Table 5: Transcripts overrexpressed in IMF samples with JAK2V617F mutation
View article: Supplementary Table 3 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis
Supplementary Table 3 from Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis Open
Supp Table 3: Loci that are differentially hypomethylated in IMF with JAK2V617F mutations when compared to controls
View article: Advancing drug development in myelodysplastic syndromes
Advancing drug development in myelodysplastic syndromes Open
Myelodysplastic syndromes/neoplasms (MDSs) are heterogeneous stem cell malignancies characterized by poor prognosis and no curative therapies outside of allogeneic hematopoietic stem cell transplantation. Despite some recent approvals by t…
View article: Figure S5 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S5 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data showing Malat1 depletion has no effect on myelopoiesis or self-renewal
View article: Figure S1 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S1 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 1 but which were not included in the main figure
View article: Table S1 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Table S1 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
gRNAs for generation of MALAT1 knockout THP-1 cells (related to Fig S7)
View article: Figure S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 3 but which were not included in the main figure
View article: Table S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Table S4 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Taqman assays for murine cytokine gene expression (related to Fig S6)
View article: Table S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Table S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
guide RNA for T7 knockdown of TET2 (related to Fig 1, Fig S1)
View article: Table S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Table S3 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
qRT-PCR primer sequences (related to Fig 1, Fig S3, Fig S7)
View article: Figure S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S6 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 5 but which were not included in the main figure
View article: Table S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Table S2 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
qRT-PCR primers for confirming MALAT1 knockout across transcript. (Related to Fig S7)
View article: Figure S7 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis
Figure S7 from RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in <i>TET2</i>-Mutated Clonal Hematopoiesis Open
Contains data related to Figure 6 but which were not included in the main figure